ABCB4 p.Met113Leu
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 19018976
[PubMed]
Nakken KE et al: "ABCB4 sequence variations in young adults with cholesterol gallstone disease."
No.
Sentence
Comment
62
These were c.337A4G/p.M113L, c.523A4G/p.T175A, c.1584G4 C/ p.E528D, c.1769G4 A/p.R590Q, c.1954A4G/p.R652G and c.3318G4 C/p.Q1106H).
X
ABCB4 p.Met113Leu 19018976:62:22
status: NEW69 The c.337A4G variant is located in exon 5 (c.337A4G) and results in change of residue 113 from a methionine to leucine (p.M113L).
X
ABCB4 p.Met113Leu 19018976:69:122
status: NEW86 Four of the eight identified ABCB4 gene variants have not been reported before (p.M113L, p.Q1106H, p.Y467F fsX25 and p.R1046X).
X
ABCB4 p.Met113Leu 19018976:86:82
status: NEW88 Table 1. Summary of patient characteristics having ABCB4 gene variations with possible effects on the ABCB4 protein and the occurrence of these variations in healthy controls Patient (ID) (n = 104) Gender/ethnicity Age Indication for surgery Gallstone Location Nucleotide change Peptide change Status Controls (n = 95) 1-16 Female Exon 16 c.1954A 4 G p.R652G 9 17-22 Female/Norwegian 21 Choledocholithiasis Multiple, 5 mm Exon 6 c.523A 4 G p.T175A heterozygous 3 Female/Iraq 25 Cholecystolithiasis Multiple, 5-10 mm Female/Norwegian 28 Cholecystolithiasis Two, 15 mm Female/African 31 Cholecystitis Multiple, 5 mm1solitary, 20 mm Female/Norwegian 32 Cholecystolithiasis Multiple, 5 mm Female/Norwegian 34 Cholecystolithiasis Multiple, 5-10 mm 23 Female/Norwegian 32 Cholecystolithiasis Two, 20 mm Exon 14 c.1584G 4 C p.E528D heterozygous 0 24-25 Female/Norwegian 23 Cholecystolithiasis Multiple, 5 mm Exon 15 c.1769G 4 A p.R590Q heterozygous 1 Female/Norwegian 37 Cholecystolithiasis Multiple, o 5 mm 26 Female/Norwegian 40 Cholecystitis Solitary, 30 mm Exon 25 c.3136C 4 T p.R1046X heterozygous - 27 Female/Pakistani 30 Cholecystolithiasis Three, 10 mm Exon 13 c.1399_1400 ins10 p.Y467F fsX25 heterozygous - 28 Ã Female/Pakistani 32 Cholecystolithiasis Multiple, o 5 mm Exon 5 c.337A 4 G p.M113L heterozygous 0 Exon 26 c.3318G 4 C p.Q1106H 0 The variation p.R652G, considered to be without functional significance for the ABCB4 product, is shown without patient characteristics (16 patients).
X
ABCB4 p.Met113Leu 19018976:88:1296
status: NEW94 Grantham values range from 5 to 215; low values ( o 50) indicate chemical similarity and high values ( 4 50) indicate more radical differences) Scoring Systems for Nonsynonymous Variants Amino acid change Grantham Blosum62 SIFT PolyPhen EC/EU p.M113L 15 2 0.17 1.211 EC p.T175A 58 0 0 0.845 EC p.E528D 45 2 0.25 0.617 EC p.R590Q 43 1 0 1.951 EC p.R652G 125 À 2 0.42 1.237 EU p.Q1106H 24 0 0.03 0.185 EC Blosum62 values range from À 4 to13, with negative values indicating less acceptable and positive values indicating more acceptable substitutions.
X
ABCB4 p.Met113Leu 19018976:94:245
status: NEW109 One Pakistani patient was apparently compound heterozygous for p.M113L and p.Q1106H.
X
ABCB4 p.Met113Leu 19018976:109:65
status: NEW111 None of the controls were found to be heterozygous for c.337A4G (p.M113L) and c.3318G 4 C (p.Q1106H).
X
ABCB4 p.Met113Leu 19018976:111:67
status: NEW112 Because the controls were of Norwegian origin, c.337A4G (p.M113L) and c.3318G 4 C (p.Q1106H), the finding in this patient could just reflect that these two variations are common among individuals of Pakistani origin.
X
ABCB4 p.Met113Leu 19018976:112:59
status: NEW113 The predictive tools suggest that neither p.M113L nor p.Q1106H affects the function of ABCB4.
X
ABCB4 p.Met113Leu 19018976:113:44
status: NEW114 Thus, at present, we cannot conclude about the roles of p.M113L or p.Q1106H in gallstone disease.
X
ABCB4 p.Met113Leu 19018976:114:58
status: NEW